Nonproliferative diabetic retinopathy (NPDR) is the early stage of diabetic eye disease, where high blood sugar damages the tiny blood vessels in the retina but new abnormal vessels haven’t started growing yet. It affects roughly 7.8 million Americans and is the most common form of diabetic retinopathy. In its earliest phase, NPDR often causes no noticeable symptoms, which is why regular eye exams matter so much for people with diabetes.
What Happens Inside the Eye
The retina is lined with a dense network of microscopic blood vessels that deliver oxygen and nutrients to the cells responsible for vision. In diabetes, chronically elevated blood sugar damages these vessels through three overlapping processes that can begin before anything is visible on a standard eye exam.
First, the cells that wrap around and support blood vessel walls (called pericytes) start to break down. Pericytes act like adjustable scaffolding, helping vessels expand and contract to regulate blood flow. When they’re lost, the vessel walls weaken and bulge outward, forming tiny balloon-like pouches called microaneurysms. These are the earliest sign an eye doctor can detect.
Second, the blood-retinal barrier breaks down. This barrier normally works like a filter, keeping fluid and large molecules from leaking out of blood vessels into surrounding retinal tissue. In NPDR, that filter becomes porous. Fluid, fats, and proteins seep into the retina, causing swelling and leaving behind yellowish fatty deposits called hard exudates. This barrier breakdown has been shown to occur even before any visible retinopathy appears on examination.
Third, some capillaries close off entirely, cutting blood supply to patches of retina. These areas of poor blood flow create small zones of tissue damage, visible as pale, fluffy spots called cotton wool spots. As closure worsens, the retina responds by rerouting blood through abnormal-looking channels within its own layers.
Stages of NPDR
NPDR is graded into three severity levels based on what an eye doctor sees during a dilated exam or on retinal photographs.
- Mild NPDR: Only microaneurysms are present. These look like tiny red dots, each smaller than the width of a human hair. Many people stay at this stage for years.
- Moderate NPDR: More extensive changes appear, including dot-and-blot hemorrhages (small areas of bleeding within deeper retinal layers), hard exudates, and cotton wool spots. The damage is more widespread but hasn’t yet reached the threshold that signals high risk.
- Severe NPDR: Bleeding and vessel abnormalities are now extensive across the retina. This stage carries a meaningful risk of progressing to proliferative diabetic retinopathy (PDR), the advanced form where new, fragile blood vessels grow on the retinal surface and can cause serious vision loss. In a large Danish study of over 200,000 patients, about 3.6% of people with severe NPDR progressed to PDR within one year, and roughly 15% did so within five years.
Symptoms You Might Notice
In mild and moderate NPDR, most people notice nothing at all. Vision can remain perfectly sharp for years while damage accumulates silently in the background. This is the central challenge of the disease: by the time symptoms appear, significant harm may already be done.
As NPDR worsens, some people begin to experience blurred vision, floating spots or dark strings in their field of view, or patches that seem darker or emptier than usual. These symptoms tend to come on gradually rather than suddenly, which makes them easy to dismiss or attribute to aging.
Diabetic Macular Edema: The Main Threat to Vision
The most common way NPDR causes actual vision loss is through diabetic macular edema (DME). This happens when fluid leaking from damaged vessels accumulates in the macula, the small central area of the retina responsible for sharp, detailed vision. Reading, recognizing faces, and driving all depend heavily on the macula.
DME can develop at any stage of NPDR, not just the severe form. Research shows that people with macular edema have significantly worse visual acuity compared to those at the same stage of retinopathy without it. The swelling is measurable on imaging: the central retina thickens beyond its normal dimensions, and this thickening correlates directly with how much vision is affected. Importantly, DME is treatable, which is one of the strongest arguments for catching it early through routine screening.
How NPDR Is Detected
A dilated eye exam remains the foundation of screening. Your eye doctor places drops in your eyes to widen the pupils, then examines the retina directly or photographs it. This simple process can reveal microaneurysms, hemorrhages, and other telltale signs.
For a more detailed look, two imaging technologies play important roles. Optical coherence tomography (OCT) uses light waves to create cross-sectional images of the retina, allowing doctors to measure retinal thickness and detect macular edema with precision. A newer version, OCT angiography, maps the retinal blood vessel network without requiring any dye injection. It can detect reduced blood flow and vessel dropout earlier than traditional methods, sometimes before visible signs of retinopathy appear on a standard exam.
Fluorescein angiography, where a dye is injected into a vein and photographed as it flows through retinal vessels, is still used for staging and monitoring. It clearly highlights leaking vessels and areas of poor blood flow, though it’s limited to the superficial vessel layer and can’t visualize deeper capillary networks as well as OCT angiography can.
Recommended Screening Schedule
The American Academy of Ophthalmology recommends that people with type 2 diabetes have their first retinal screening at the time of diagnosis, then at least once a year after that. For type 1 diabetes, annual screening should begin five years after onset. The five-year delay for type 1 reflects the fact that retinopathy rarely develops that early in the disease course, whereas people newly diagnosed with type 2 may have had undetected high blood sugar for years before their diagnosis.
If NPDR is found, your eye doctor may recommend more frequent visits depending on the severity. Someone with mild NPDR and stable blood sugar might be seen every 9 to 12 months, while someone with severe NPDR could need visits every few months to watch for progression.
Slowing Progression
Blood sugar control is the single most powerful lever for slowing NPDR. Keeping your HbA1c below 7% (a measure of average blood sugar over two to three months) consistently reduces the risk of the disease getting worse. This doesn’t mean the damage reverses, but the rate of progression drops substantially.
Blood pressure control matters nearly as much. Keeping blood pressure below 140/90 mmHg protects retinal blood vessels from the additional stress that hypertension adds on top of diabetes-related damage. Cholesterol management rounds out the picture, since high lipid levels contribute to the fatty deposits that accumulate in the retina.
For mild and moderate NPDR without macular edema, no eye-specific treatment is typically needed. The focus is entirely on managing diabetes, blood pressure, and cholesterol. When DME develops or NPDR reaches the severe stage, your eye doctor may recommend treatments like injections that block the growth signals driving vessel leakage, or laser therapy to reduce swelling and slow progression toward the proliferative stage.